AMSBIO

AMSBIO is a long-established, private company that provides essential tools and services to the global life science research community. Its business model is centered on supplying high-quality reagents, antibodies, and cell culture products, particularly for advanced fields like cell and gene therapy. While not a therapeutic developer itself, AMSBIO occupies a vital niche in the research supply chain, generating revenue through its product sales and contract services. The company's strategic location in Basel, a major European biopharma hub, positions it close to key customers and partners.

Portfolio of research reagents, cell culture products, and technical services supporting cell therapy, genomics, and antibody-based research. Includes viral vectors, extracellular matrices, custom antibodies, and contract testing/development services.

Operates in a crowded market competing against giants like Thermo Fisher Scientific, Merck KGaA, and Sartorius, as well as numerous specialized reagent companies. Differentiation is achieved through technical expertise, a focused product portfolio in high-growth niches, and a strong service component, rather than scale alone.